Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
Getein SARS-CoV-2 Neutralizing Antibody Fast Test Kit (Immunofluorescence Assay) is used as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, it should not be used to diagnose acute SARS-CoV-2 infection.
Getein One Step Test for SARS-CoV-2 Total Antibody/ Neutralizing Antibody (Colloidal Gold) is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus.
Subscribe to our weekly newsletter and receive exclusive offers on products you love!
X
